David P. Al-Adra, MD, PhD, FACS

Assistant Professor

  • Division of Transplantation 

aladra@surgery.wisc.edu
(608) 263-0388

Clinical Science Center
600 Highland Avenue
Madison WI 53792

Education

  • MD, University of Alberta
  • PhD, Clinical Investigator Program in the Department of Surgery, University of Alberta
  • Residency, General Surgery, University of Alberta
  • Abdominal Organ Transplant Fellowship, University of Toronto

Clinical Specialties

Dr. Al-Adra is certified by the American Board of Surgery (ABS), the American Society of Transplant Surgeons (ASTS), the Royal College of Surgeons of Canada, and the Americas Hepato-Pancreato-Biliary Association (AHPBA). He specializes in liver, kidney, pancreas and pediatric transplantation, live donor liver transplantation (LDLT), and hepatobiliary surgery.

Research Interests

Dr. Al-Adra is investigating the mechanisms of immunological rejection after solid organ transplantation. The goal of his research is to decrease the immune response against the organ, which would then decrease the need for anti-rejection drugs. Specifically, the transplanted organs can be modified using normothermic machine organ preservation technologies to decrease rejection after transplantation.

Learn more about Dr. Al-Adra’s lab here. 

Dr. Al-Adra was recently awarded a one-year, $65,000 grant from UW’s 2023 Fall Research Competition, which is administered by the Office of the Vice Chancellor for Research. Read more here.

Recent Publications

  • What Is Hot and New in Basic and Translational Science in Liver Transplantation in 2023? Report of the Basic and Translational Research Committee of the International Liver Transplantation Society.
    Bonaccorsi-Riani E, Ghinolfi D, Czigany Z, Dondossola D, Emamaullee J, Yuksel M, Boteon YL, Al-Adra D, Ho CM, Abdelrahim M, Pang L, Barbas A, Meier R, MacParland S, Sayed BA, Pavan-Guimaraes J, Brüggenwirth IMA, Zarrinpar A, Mas VR, Selzner M, Martins PN, Bhat M
    Transplantation 2024 Mar 18;
    [PubMed ID: 38494468]

  • Premalignant Lesions in the Kidney Transplant Candidate.
    Schroder PM, Biesterveld BE, Al-Adra DP
    Semin Nephrol 2024 Mar 14; 151495
    [PubMed ID: 38490902]

  • Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies.
    Verhoven B, Zeng W, Chlebeck P, Matkowskyj K, Jennings H, Poore S, Al-Adra D
    J Vis Exp 2024 Mar 08;
    [PubMed ID: 38526116]

  • Analysis of >15 000 Solid Organ Transplant Recipients Reveals Nonanal Genitourinary HPV-related Disease as Highest Risk Predictor for Anal Squamous Intraepithelial Lesions/Anal Cancer.
    Freeman MJ, Yang Q, Cherney-Stafford L, Striker R, Foley DP, Al-Adra DP, Sanger CB
    Transplantation 2024 Feb 22;
    [PubMed ID: 38383963]

  • Detrimental impact of early biopsy-proven rejection in liver transplantation.
    Aufhauser DD, Stalter L, Marka N, Leverson G, Al-Adra DP, Foley DP
    Clin Transplant 2024 Jan; 38(1): e15206
    [PubMed ID: 38041491]

All Publications on PubMed